China Health Group Inc. (HKG:8225)
0.1090
0.00 (0.00%)
Jun 18, 2026, 3:00 PM HKT
China Health Group Company Description
China Health Group Inc., together with its subsidiaries, researches and develops bio, natural, and synthetic drugs in the People’s Republic of China.
It engages in the pharmacodynamics and clinical research of drugs; provision of post market and contracted pharmaceutical development services; and technological transfer and services for the research and development of drugs.
The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in February 2015.
China Health Group Inc. was founded in 1998 and is headquartered in Beijing, China.
China Health Group Inc.
| Country | Cayman Islands |
| Founded | 1998 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 32 |
Contact Details
Address: Building 17 Beijing China | |
| Phone | 86 21 6115 8121 |
| Website | chgi.net |
Stock Details
| Ticker Symbol | 8225 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG2117N1088 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Xia Guo MBA, MSc, Ph.D. | Executive Chairman |
| Guo Raymond | Executive Director and Chief Artificial Intelligence Officer |
| Liang Li | Financial Director |
| Dr. Tuo Jin | Joint Chief Technology Officer and Member of Scientific Advisory Board |
| Dr. Xuemei Song | Head of Human Resources Mgmt Dept |
| Tsz Ngo Yu | Company Secretary |
| Dr. Yiu Kwong Sun B.S., M.B., M.D. | Adviser for Medical Affairs and Member of Corporate Advisory Board |